Stockreport

Applied Therapeutics: A Strong Buy With AT-007 Nearing Approval For Galactosemia [Seeking Alpha]

Applied Therapeutics, Inc.  (APLT) 
Last applied therapeutics, inc. earnings: 11/13 07:00 am Check Earnings Report
PDF Govorestat (AT-007) is in late-stage regulatory approval for galactosemia, with a PDUFA date set for November 2024. APLT holds $146.5 million in cash, ensuring a suff [Read more]